Integer Holdings (ITGR) Cash from Financing Activities (2010 - 2026)

Integer Holdings (ITGR) reported Cash from Financing Activities of $3.8 million for Q2 2026, down 97.47% on a YoY basis from $151.6 million in Q2 2025, and up 106.21% sequentially from -$61.7 million in Q4 2025.

Integer Holdings (ITGR) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Integer Holdings (ITGR) has 17 years of Cash from Financing Activities data on file, last reported at $3.8 million in Q2 2026.

  • For the quarter ending Q2 2026, Cash from Financing Activities fell 97.47% year-over-year to $3.8 million; the trailing twelve-month figure through Apr 2026 stood at -$104.2 million (down 6591.59% YoY), and the FY2025 full-year result was $43.6 million, up 226.99% from the prior year.
  • Cash from Financing Activities improved to $3.8 million in Q2 2026, from -$61.7 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $163.3 million in Q1 2024 to a low of -$82.3 million in Q4 2024.
  • A 5-year average of $8.0 million and a median of -$10.7 million in 2025 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities surged 3321.4% in 2023 and sank 569.69% in 2024, its largest moves.
  • Tracing ITGR's Cash from Financing Activities over 5 years: stood at -$13.9 million in 2022, then soared by 225.74% to $17.5 million in 2023, then slumped by 569.69% to -$82.3 million in 2024, then increased by 25.01% to -$61.7 million in 2025, then jumped by 106.21% to $3.8 million in 2026.
  • Business Quant data shows ITGR's Cash from Financing Activities at $3.8 million in Q2 2026, -$61.7 million in Q4 2025, and -$10.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 17.31 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -1.51 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -451.20 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -25.00 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -26.93 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 21.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Integer Holdings 3.34 Bn 3.33 Bn 109.60 Mn 3.83 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 3.83 Mn
Apr 3, 2026 3.83 Mn
Dec 31, 2025 -61.72 Mn
Dec 31, 2025 -61.72 Mn
Sep 26, 2025 -10.71 Mn
Sep 26, 2025 -10.71 Mn
Jun 27, 2025 -35.59 Mn
Jun 27, 2025 -35.59 Mn
Mar 28, 2025 151.58 Mn
Mar 28, 2025 151.58 Mn
Dec 31, 2024 -82.30 Mn
Dec 31, 2024 -82.30 Mn
Sep 27, 2024 -43.14 Mn
Sep 27, 2024 -43.14 Mn
Jun 28, 2024 -24.53 Mn
Jun 28, 2024 -24.53 Mn
Mar 29, 2024 163.29 Mn
Mar 29, 2024 163.29 Mn
Dec 31, 2023 17.52 Mn
Dec 31, 2023 17.52 Mn